From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
This article needs cleanup to meet MEpedia's guidelines.
This page needs additional references or sources for verification - multiple references need to be added. (February 2021)
Leukotriene inhibitors[edit | edit source]
Leukotriene inhibitors are a potential treatment for mast cell diseases including mast cell activation syndrome.
Learn more[edit | edit source]
- Medications to Treat Mast Cell Diseases - The Mast Cell Disease Society
See also[edit | edit source]
References[edit | edit source]
- "Medications to Treat Mast Cell Diseases". The Mast Cell Disease Society. Retrieved February 16, 2021.